FDA-Inspected Site

Centaur Pharmaceuticals Private Limited

2 FDA inspections are on record for Centaur Pharmaceuticals Private Limited in Pernem, India.

Clean· No action indicated

Pernem, India · Last updated August 15, 2026

Overview

  • 2 FDA inspections are on record.
  • 1 inspection produced a Form 483.
  • The most recent recorded inspection date is 2025-11-14.

At a glance

Inspections

2

Form 483s

1

EIRs

0

Last outcome

Clean

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
10 Nov 2025 – 14 Nov 2025Human DrugsClean
9 Jan 2023 – 13 Jan 2023Human Drugs483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

13 Jan 2023
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Sandra A Boyd

13 Jan 2023
21 CFR 211.110(b)

In-process specification, invalid

Cited by Sandra A Boyd

13 Jan 2023
21 CFR 211.113(a)

Procedures for non-sterile drug products

Cited by Sandra A Boyd

13 Jan 2023
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Sandra A Boyd

13 Jan 2023
21 CFR 211.166(a)(3)

Valid stability test methods

Cited by Sandra A Boyd

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.110(b)Cited across public-safe Form 483 observations1x
21 CFR 211.113(a)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.166(a)(3)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Centaur Pharmaceuticals Private Limited's 1 Form 483

Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat